DTC Advertising

Patient Attitudes Toward DTC Advertising

Revisiting Aspects of the 2004 Landmark FDA Study

Biopharmaceutical spend on DTC continues to grow, even in the face of negative statements from leadership in government, the medical community, and patient advocacy. What do patients think about advertising for prescription drugs? What channels would patients prefer to use when looking for health information?

In November 2004, the FDA released a final report on the findings of a study that explored patient and physician perspectives on DTC advertising as it relates to the healthcare experience. Our current research asks more than 500 consumers a subset of the questions originally fielded by the FDA to determine how attitudes have changed over the last decade. Analysis also examines current consumer preferences for program types and communication channels to assist marketers in choosing the best options for their target audiences.

Products Available:

Quantitative Report – Overall Findings 45 pp, Powerpoint format $6,500
Quantitative Report – Comparing the Chronically Ill vs the Occasionally Ill 30 pp, Powerpoint format $2,500
Infographics Now and Then Snapshot
Patient Program & Channel Preferences
Quantitative Data Tables Banner 1: Gender, Age, Race
Banner 2: Condition
Banner 3: Insurance Status, Treatment Segment

After you complete and submit the form below, we will contact you when the reports are available to arrange payment. Please note the reports you would like to order in the message box. All products are delivered electronically and can be printed upon receipt.


Pre-Order Form

To purchase or learn more about these products, enter your contact information below and indicate which contact method works best for you. A representative will be in touch shortly.